MMP8 and triple-A syndrome: Increased levels of MMP-8 and MMP-9 have also been identified at the site of AAA rupture.19 However, measurement of plasma concentrations of these biomarkers has not been demonstrated to be of value in clinical risk prediction of patients and this likely reflects a lack of sensitivity.